ATE516806T1 - Ivabradin und seine verwendung in einer diagnosemethode unter einsatz der koronaren angiographie durch mehrschicht- computertomographie - Google Patents

Ivabradin und seine verwendung in einer diagnosemethode unter einsatz der koronaren angiographie durch mehrschicht- computertomographie

Info

Publication number
ATE516806T1
ATE516806T1 AT09290841T AT09290841T ATE516806T1 AT E516806 T1 ATE516806 T1 AT E516806T1 AT 09290841 T AT09290841 T AT 09290841T AT 09290841 T AT09290841 T AT 09290841T AT E516806 T1 ATE516806 T1 AT E516806T1
Authority
AT
Austria
Prior art keywords
ivabradine
diagnostic method
computer tomography
coronary angiography
slice computer
Prior art date
Application number
AT09290841T
Other languages
English (en)
Inventor
Guy Lerebours-Pigeonniere
Ariane Dubost-Brama
Carmen Fleurinck
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40677692&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE516806(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE516806T1 publication Critical patent/ATE516806T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT09290841T 2008-11-07 2009-11-06 Ivabradin und seine verwendung in einer diagnosemethode unter einsatz der koronaren angiographie durch mehrschicht- computertomographie ATE516806T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806225A FR2938194B1 (fr) 2008-11-07 2008-11-07 Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe

Publications (1)

Publication Number Publication Date
ATE516806T1 true ATE516806T1 (de) 2011-08-15

Family

ID=40677692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09290841T ATE516806T1 (de) 2008-11-07 2009-11-06 Ivabradin und seine verwendung in einer diagnosemethode unter einsatz der koronaren angiographie durch mehrschicht- computertomographie

Country Status (44)

Country Link
US (2) US20100119459A1 (de)
EP (1) EP2184065B1 (de)
JP (3) JP2010111673A (de)
KR (1) KR101168484B1 (de)
CN (1) CN101732734A (de)
AP (1) AP2635A (de)
AR (1) AR074294A1 (de)
AT (1) ATE516806T1 (de)
AU (1) AU2009235984B2 (de)
BR (1) BRPI0904376A2 (de)
CA (1) CA2685303C (de)
CL (1) CL2009002032A1 (de)
CO (1) CO6230160A1 (de)
CR (1) CR11094A (de)
CY (1) CY1112037T1 (de)
DK (1) DK2184065T3 (de)
EA (1) EA017641B1 (de)
EC (1) ECSP099715A (de)
ES (1) ES2370145T3 (de)
FR (1) FR2938194B1 (de)
GE (1) GEP20135729B (de)
GT (1) GT200900288A (de)
HR (1) HRP20110684T1 (de)
IL (1) IL201815A (de)
JO (1) JO2838B1 (de)
MA (1) MA31418B1 (de)
ME (1) ME00953B (de)
MX (1) MX2009012014A (de)
MY (1) MY145991A (de)
NI (1) NI200900195A (de)
NZ (1) NZ580984A (de)
PA (1) PA8847801A1 (de)
PE (1) PE20100744A1 (de)
PL (1) PL2184065T3 (de)
RS (1) RS51948B (de)
SA (1) SA109300653B1 (de)
SG (1) SG161186A1 (de)
SI (1) SI2184065T1 (de)
SV (1) SV2009003401A (de)
TW (1) TWI426923B (de)
UA (1) UA101612C2 (de)
UY (1) UY32202A (de)
WO (1) WO2010052394A1 (de)
ZA (1) ZA200907753B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011157721A2 (en) 2010-06-14 2011-12-22 Ratiopharm Gmbh Ivabradine-containing pharmaceutical composition
CN106580873A (zh) * 2016-11-08 2017-04-26 北京万全德众医药生物技术有限公司 伊伐布雷定或其可药用盐口服溶液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
WO2005014042A1 (ja) 2003-08-08 2005-02-17 Ono Pharmaceutical Co., Ltd. 短時間型β遮断薬を有効成分とする心拍数減少剤
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
FR2911279B1 (fr) * 2007-01-11 2009-03-06 Servier Lab Utilisation de l'ivabradine pour l'obtention de medicaments destines au traitement de la dysfonction endotheliale

Also Published As

Publication number Publication date
ME00953B (de) 2012-06-20
SI2184065T1 (sl) 2011-10-28
GEP20135729B (en) 2013-01-25
SA109300653B1 (ar) 2013-05-18
UY32202A (es) 2010-06-30
AR074294A1 (es) 2011-01-05
PA8847801A1 (es) 2010-06-28
CY1112037T1 (el) 2015-11-04
PE20100744A1 (es) 2010-10-30
KR101168484B1 (ko) 2012-07-26
CN101732734A (zh) 2010-06-16
IL201815A0 (en) 2010-06-30
JP2013049699A (ja) 2013-03-14
CO6230160A1 (es) 2010-12-20
EP2184065B1 (de) 2011-07-20
AP2635A (en) 2013-04-05
MA31418B1 (fr) 2010-06-01
MY145991A (en) 2012-06-08
RS51948B (sr) 2012-02-29
CL2009002032A1 (es) 2010-09-10
GT200900288A (es) 2012-01-31
CA2685303C (fr) 2012-04-17
AU2009235984A1 (en) 2010-05-27
JP2016040304A (ja) 2016-03-24
FR2938194B1 (fr) 2012-08-31
US20160361444A1 (en) 2016-12-15
MX2009012014A (es) 2010-05-27
BRPI0904376A2 (pt) 2011-09-06
AU2009235984B2 (en) 2011-05-12
ECSP099715A (es) 2010-06-29
EA017641B1 (ru) 2013-02-28
JO2838B1 (en) 2014-09-15
JP6029935B2 (ja) 2016-11-24
TWI426923B (zh) 2014-02-21
NZ580984A (en) 2010-12-24
SV2009003401A (es) 2010-02-17
TW201021834A (en) 2010-06-16
CA2685303A1 (fr) 2010-05-07
PL2184065T3 (pl) 2011-12-30
CR11094A (es) 2009-12-02
EP2184065A1 (de) 2010-05-12
US20100119459A1 (en) 2010-05-13
EA200901369A1 (ru) 2011-06-30
ES2370145T3 (es) 2011-12-13
IL201815A (en) 2013-08-29
JP2010111673A (ja) 2010-05-20
ZA200907753B (en) 2010-07-28
AP2009005035A0 (en) 2009-12-31
DK2184065T3 (da) 2011-10-24
HRP20110684T1 (hr) 2011-10-31
SG161186A1 (en) 2010-05-27
WO2010052394A1 (fr) 2010-05-14
KR20100051549A (ko) 2010-05-17
NI200900195A (es) 2011-08-03
FR2938194A1 (fr) 2010-05-14
UA101612C2 (uk) 2013-04-25

Similar Documents

Publication Publication Date Title
BRPI0908886A2 (pt) aparelho, método e programa de computador pra segmentar um objeto, e, modelo de objeto
DE112010004772T8 (de) Verfahren und System zum Verwalten von Konfigurationen von Systemverwaltungsagenten in einer Verteilten Umgebung
BRPI0910408A2 (pt) equipamento e método para gerenciamento de memória relacionado a widget.
EP2248302A4 (de) Repräsentation qualitativer objektänderungen in einem auf wissen basierenden rahmen für eine mehrfach-master-synchronisationsumgebung
BR112012031417A2 (pt) aparelho portátil integrado para adquirir informação de diagnóstico e prognóstico de um paciente no leito ou em algum outro local onde o paciente estiver, haste e método para adquirir informação de diagnóstico e prognóstico de um paciente no leito ou em algum outro local onde o paciente estiver
EP2352671A4 (de) Fahrwerkladetür mit doppelhakenmechanismus
EP2736456A4 (de) Künstliche leitungen mit ventilen für herzrekonstruktionsbehandlungen und verfahren zu ihrer herstellung
Van Hop Solving fuzzy (stochastic) linear programming problems using superiority and inferiority measures
BR112013009480A2 (pt) método de proução de um aestrutura em sanduíche, utilização de uma estrutura absorvente e aparelho de produção de uma estrutura compósita
FI20085997L (fi) Menetelmä ksyloosin ja liukosellun valmistamiseksi
EP2441814A4 (de) Wärmedehnbare mikrokugeln, verfahren zu ihrer herstellung und verwendung davon
EP2208465A4 (de) Ultraschallgerät, betriebsverfahren dafür und ultraschalldiagnoseprogramm
EP2541611A4 (de) Vorrichtung und verfahren zur fehlerdiagnose
BRPI1005165A2 (pt) Aparelho, método e programa de computador para obter um parâmetro que descreve uma variação de uma caracteristica de sinal de um sinal
BRPI0822945A2 (pt) Método de planejamento de recurso de empregado, sistema de planejamento de recurso de empregado e produto de programa de computador
PL2530093T3 (pl) Związek indocyjaninowy, jego metoda syntezy, metoda jego oczyszczania, kompozycja diagnostyczna wykorzystująca związek indocyjaninowy oraz urządzenie do pomiaru biokinetyki in vivo i urządzenie do wizualizacji krążenia wykorzystujące kompozycję diagnostyczną
EP2286401A4 (de) Reagierendes buchsystem und verfahren dafür
EP2590094A3 (de) Computergestütztes Gestaltungsmodell-Analysesystem
ZA201003901B (en) Method of determining the value of a parameter representative of the operability of a nuclear reactor, determining system, computer program and corresponding support
EP2259787A4 (de) Ikki-hemmer-therapien und -screeningverfahren sowie entsprechende ikki-diagnoseverfahren
DE112007001677A5 (de) System mit einer medizinischen Gammasonde und einem Steuergerät
EP2607507A4 (de) Hochfestes titanlegierungselement und verfahren zu seiner herstellung
GB2459814B (en) Measuring method, measuring device, and computer program
EP2321320A4 (de) Neuartige verbindungen und ihre verwendung zu diagnosezwecken
GB0821726D0 (en) Enterprise resource planning system with asynchronous notifications of background processing events

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2184065

Country of ref document: EP